Delivery Order SPE2DB20D1109-SPE2DB22FP98X
- Not listed
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,951.97 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 29, 2023. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $7,003.02 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of RABAVERT rabies vaccine with diluents. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,158.18 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of RABAVERT rabies vaccine with diluents. This contract is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract does not have a set-aside designation, indicating it was awarded through full and open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,930.30 firm-fixed price delivery order is for the supply of RABAVERT rabies vaccine with diluents. The contract has a performance period through March 27, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of RABAVERT rabies vaccine with diluents. The contract has a not-to-exceed value of $10,883.21 and runs through December 20, 2023. It is a firm-fixed price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the delivery of RABAVERT rabies vaccine with diluents. The single-award Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of RABAVERT Rabies Vaccine with diluents. The $36,858.00 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents to the Defense Logistics Agency (DLA). The contract, valued at $27,024.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of RABAVERT rabies vaccine with diluents (Contract ID: SPE2DX15D3006|SPE2DX23F02YP) with a total ceiling value of $4,448.97. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, on May 18, 2023, with a completion date of May 19, 2023. The contract is a firm fixed-price delivery order, and no set-aside designation was used. Amerisourcebergen...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract was issued by the Defense Logistics Agency (DLA), a defense agency, and has a ceiling value of $3,986.56. The contract is a delivery order, with a firm fixed price pricing type and an ultimate completion date of July 25, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FP98XDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $20,290.20 for the supply of RABAVERT rabies vaccine with diluents. The award was made by the Defense Logistics Agency (DLA), a defense agency, on August 31, 2022, with a completion date of September 1, 2022. The contract is a firm-fixed price delivery order, without any set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999.00 and $750,000.00 respectively, for the provision of a wide range of pharmaceutical products and medical supplies to support federal healthcare programs, including those serving the military and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.3k | 8/31/22 |